These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37313933)

  • 1. Variation in normative values of major clinical biochemistry analytes in healthy reproductive-age women in India: A subset of data from a National Indian Council of Medical Research-Polycystic Ovary Syndrome task force study.
    Ganie MA; Chowdhury S; Suri V; Joshi BN; Bhattacharya PK; Agarwal S; Malhotra N; Sahay R; Jabbar PK; Rozati R; Shukla A; Rashid H; Bashir R; Wani I; Nair A; Arora TK; Kulkarni B
    Indian J Pharmacol; 2023; 55(2):76-88. PubMed ID: 37313933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing reference intervals for major biochemical analytes for the Russian population: a research conducted as a part of the IFCC global study on reference values.
    Evgina S; Ichihara K; Ruzhanskaya A; Skibo I; Vybornova N; Vasiliev A; Kimura S; Butlitski D; Volkova E; Vilenskaya E; Emanuel V
    Clin Biochem; 2020 Jul; 81():47-58. PubMed ID: 32278594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Concordance of Telemedicine as Compared With Face-to-Face Care in Primary Health Care Clinics in Rural India: Randomized Crossover Trial.
    Verma N; Buch B; Taralekar R; Acharya S
    JMIR Form Res; 2023 Jun; 7():e42775. PubMed ID: 37130015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reference intervals for 33 biochemical analytes in healthy Indian population: C-RIDL IFCC initiative.
    Shah SAV; Ichihara K; Dherai AJ; Ashavaid TF
    Clin Chem Lab Med; 2018 Nov; 56(12):2093-2103. PubMed ID: 30074895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Prevalence, Regional Phenotypic Variation, Comorbidities, Risk Factors, and Variations in Response to Different Therapeutic Modalities Among Indian Women: Proposal for the Indian Council of Medical Research-Polycystic Ovary Syndrome (ICMR-PCOS) Study.
    Ganie MA; Chowdhury S; Suri V; Joshi B; Bhattacharya PK; Agrawal S; Malhotra N; Sahay R; Rozati R; Jabbar PK; Sreenivas V; Sriwastva M; Wani IA; Singh S; Sharma RS
    JMIR Res Protoc; 2021 Aug; 10(8):e23437. PubMed ID: 34448720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Derivation of sex and age-specific reference intervals for clinical chemistry analytes in healthy Ghanaian adults.
    Bawua SA; Ichihara K; Keatley R; Arko-Mensah J; Ayeh-Kumi PF; Erasmus R; Fobil J
    Clin Chem Lab Med; 2022 Aug; 60(9):1426-1439. PubMed ID: 35786502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of community-based reference ranges to estimate the prevalence of polycystic ovary syndrome by the recognised diagnostic criteria, a cross-sectional study.
    Skiba MA; Bell RJ; Herbert D; Garcia AM; Islam RM; Davis SR
    Hum Reprod; 2021 May; 36(6):1611-1620. PubMed ID: 33846715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glucose tolerance test significantly impacts the prevalence of abnormal glucose tolerance among Indian women with polycystic ovary syndrome: lessons from a large database of two tertiary care centers on the Indian subcontinent.
    Ganie MA; Dhingra A; Nisar S; Sreenivas V; Shah ZA; Rashid A; Masoodi S; Gupta N
    Fertil Steril; 2016 Jan; 105(1):194-201.e1-3. PubMed ID: 26407537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BMI in childhood and adolescence is associated with impaired reproductive function-a population-based cohort study from birth to age 50 years.
    Laru J; Nedelec R; Koivuaho E; Ojaniemi M; Järvelin MR; Tapanainen JS; Franks S; Tolvanen M; Piltonen TT; Sebert S; Morin-Papunen L
    Hum Reprod; 2021 Oct; 36(11):2948-2961. PubMed ID: 34364312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of reference intervals of clinical chemistry analytes for the adult population in Egypt.
    Baz H; Ichihara K; Selim M; Awad A; Aglan S; Ramadan D; Hassab A; Mansour L; Elgaddar O
    PLoS One; 2021; 16(3):e0236772. PubMed ID: 33740794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome.
    Harsha Varma S; Tirupati S; Pradeep TVS; Sarathi V; Kumar D
    Diabetes Metab Syndr; 2019; 13(2):1065-1069. PubMed ID: 31336445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of reference intervals of clinical chemistry analytes for the adult population in Saudi Arabia: a study conducted as a part of the IFCC global study on reference values.
    Borai A; Ichihara K; Al Masaud A; Tamimi W; Bahijri S; Armbuster D; Bawazeer A; Nawajha M; Otaibi N; Khalil H; Kawano R; Kaddam I; Abdelaal M;
    Clin Chem Lab Med; 2016 May; 54(5):843-55. PubMed ID: 26527074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations.
    Deswal R; Nanda S; Ghalaut VS; Roy PS; Dang AS
    Int J Gynaecol Obstet; 2019 Sep; 146(3):370-379. PubMed ID: 31220344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular myocardial mass index and its correlates as an early marker of cardiovascular risk among nonobese normotensive Indian women with polycystic ovary syndrome: lessons from a cross-sectional study.
    Rashid A; Masood A; Wani IA; Hafeez I; Parvez T; Zagar MA; Ganie MA
    Fertil Steril; 2020 Jun; 113(6):1299-1307.e2. PubMed ID: 32482259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.